Evidence map›Paper›PMID 35435708›Full record

ArticleAntimicrobial agents and chemotherapy2022

Antimicrobial Resistance among Leprosy Patients in Brazil: Real-World Data Based on the National Surveillance Plan.

Elaine Silva Nascimento Andrade, Jurema Guerrieri Brandão, Juliana Souza da Silva, Carmelita Ribeiro Filha Coriolano, Patricia Sammarco Rosa, Milton Ozório Moraes, Cynthia de Oliveira Ferreira, Ciro Martins Gomes, Wildo Navegantes de Araújo

Erratum issuedOpen access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Geographical trends of drug-resistant strains of Mycobacterium leprae in TLM hospitals: insights from a four-year study across eleven hospitals in eight Indian States.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  3. Review
  4. Hansen's disease (leprosy) in Japan, 1947-2020: an epidemiologic study during the declining phase to elimination.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
    Article
  5. Sensitivity of different DNA extraction methods and PCR to detect resistance in patients with leprosy stratified by the bacilloscopic index.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
    Article
  6. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Elaine Silva Nascimento AndradeCoordenação Geral de Doenças em Eliminação - CGDE, Departamento de Doenças de Condições Crônicas e Infecções Sexualmente Transmissíveis - DCCI, Secretaria de Vigilância em Saúde, Ministério da Saúde, Brasília, Brazil.ORCID 0000-0002-8066-8283
Jurema Guerrieri BrandãoCoordenação Geral de Doenças em Eliminação - CGDE, Departamento de Doenças de Condições Crônicas e Infecções Sexualmente Transmissíveis - DCCI, Secretaria de Vigilância em Saúde, Ministério da Saúde, Brasília, Brazil.
Juliana Souza da SilvaCoordenação Geral de Doenças em Eliminação - CGDE, Departamento de Doenças de Condições Crônicas e Infecções Sexualmente Transmissíveis - DCCI, Secretaria de Vigilância em Saúde, Ministério da Saúde, Brasília, Brazil.
Carmelita Ribeiro Filha CoriolanoCoordenação Geral de Doenças em Eliminação - CGDE, Departamento de Doenças de Condições Crônicas e Infecções Sexualmente Transmissíveis - DCCI, Secretaria de Vigilância em Saúde, Ministério da Saúde, Brasília, Brazil.
Patricia Sammarco RosaLaboratório de Biologia Molecular, Instituto Lauro de Souza Limagrid.419145.c, Bauru, Brazil.
Milton Ozório MoraesLaboratório Hanseníase, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Cynthia de Oliveira FerreiraLaboratório de Biologia Molecular, Fundação Alfredo da Matta, Manaus, Brazil.
Ciro Martins GomesPrograma de Pós-Graduação em Ciências Médicas, Faculdade de Medicina, Universidade de Brasília - UnB, Brasília, Brazil.ORCID 0000-0002-3069-6884
Wildo Navegantes de AraújoPrograma de Pós-Graduação em Saúde Coletiva, Faculdade de Medicina, Universidade de Brasília - UnB, Brasília, Brazil.
Universidade de Brasília · BRMinistério da Saúde · BRFundação Oswaldo Cruz · BRInstituto Lauro de Souza Lima · BRUniversidade do Estado do Amazonas · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brazil ranks second among countries for new cases and first for relapse cases of leprosy worldwide. The Mycobacterium leprae Resistance Surveillance Plan was established. We aimed to present the results of a 2-year follow-up of the National Surveillance Plan in Brazil. A cross-sectional study of leprosy cases was performed to investigate antimicrobial resistance (AMR) in Brazil from October 2018 to September 2020. Molecular screening targeting genes related to dapsone (

Indexed as

Leprostatic AgentsLeprosyAnti-Bacterial AgentsBrazilCross-Sectional StudiesDapsoneDrug Resistance, BacterialDrug Therapy, CombinationHumansMicrobial Sensitivity TestsMycobacterium lepraeRecurrenceRifampinAnti-Bacterial AgentsDapsoneLeprostatic AgentsRifampinBrazilDNAdrug resistanceleprosyM. lepraesequence analysissurveillance

Identifiers

PMID35435708
PMCPMC9112907
OpenAlexW4224029644

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.